Regn deadline: rosen, a leading law firm, encourages regeneron pharmaceuticals, inc. investors with losses in excess of $100k to secure counsel before important deadline in securities class action – regn

New york, feb. 26, 2025 (globe newswire) -- why: rosen law firm, a global investor rights law firm, reminds purchasers of securities of regeneron pharmaceuticals, inc. (nasdaq: regn) between november 2, 2023 and october 30, 2024, both dates inclusive (the “class period”), of the important march 10, 2025 lead plaintiff deadline.
REGN Ratings Summary
Quant
REGN Quant Ranking
Sector
Industry
Quant Rating
Quant Score